| Oct 28 |
Monte Rosa Almost Doubles — Up 94% — On A Massive Deal With Novartis
|
| Oct 28 |
This Biotech Stock Has Doubled Its Value Today—Here's Why
|
| Oct 28 |
Buy 3 Stocks Likely to Gain on Potential Q3 Earnings Beat
|
| Oct 28 |
Novartis Q3 2024 Earnings Preview
|
| Oct 28 |
NVS 2024-10-novartis-renal-portfolio-presentation
|
| Oct 28 |
Novartis AG (NVS) Renal Portfolio Update Call Transcript
|
| Oct 28 |
Novartis to pay Monte Rosa $150 million upfront to develop a new class of drugs
|
| Oct 28 |
Why Is Monte Rosa Therapeutics Stock Surging On Monday?
|
| Oct 28 |
Monte Rosa jumps on $150M license deal with Novartis
|
| Oct 28 |
Monte Rosa Therapeutics Enters Global License Deal With Novartis; Shares Jump Pre-Bell
|
